Regencell Bioscience's total assets for Q4 2024 were $8.44M, a decrease of 0.00% from the previous quarter. RGC total liabilities were $219.51K for the fiscal quarter, a 0.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.